Mr. Speaker, the jury in the Vanessa Young case heard the long chronology of events. It heard that as long ago as 1995 and 1996 Health Canada was taking out pages in the Canadian Medical Association Journal to report on reactions in relation to the drug Prepulsid.
Let us put aside the arguments and get to the bottom line. The bottom line is the health and safety of Canadians. We welcome the CMA approach. We will look at it for our own website.
Let me point something out as a matter of interest. This morning the CMA announced that one of the drugs it will put on its website is a drug in relation to which—